STAT Plus: Applied Therapeutics’ muted response to a clinical hold speaks volumes
How a company communicates with investors can be just as meaningful as what it communicates.
Take Applied Therapeutics, which used an SEC filing on Monday morning to disclose that the Food and Drug Administration placed a partial hold on one of its important clinical trials, involving its lead drug and children with a rare metabolic disease.
Continue to STAT Plus to read the full story…
